Polynucleotides Therapy

Also known as: PN Therapy · PN Injectables · Salmon DNA Skin Booster · Biorejuvenation Therapy · Trout DNA Therapy · Rejuran (brand-specific) · PhilArt (brand-specific) · Plinest (brand-specific) · Nucleofill (brand-specific)

Aesthetics

Definition

Polynucleotides Therapy is an advanced regenerative aesthetic treatment that utilizes highly purified DNA fractions, typically extracted from salmon (Salmo salar) or trout (Oncorhynchus mykiss) germ cells, to stimulate cellular repair and tissue rejuvenation. At the molecular level, these polynucleotide chains consist of monomers of nucleotides linked by phosphodiester bonds, which bind to cell membrane receptors, specifically the A2A adenosine receptors. This binding triggers a cascade of intracellular events that promote fibroblast proliferation, enhance the synthesis of type I and type III collagen, stimulate elastin production (elastogenesis), and promote new blood vessel formation (angiogenesis) (Wikipedia, MeSH).

Unlike traditional dermal fillers that physically occupy space to lift or volumize tissue, polynucleotides function as bio-stimulators. They work by improving the physiological conditions of the skin, increasing hydration through their hydrophilic phosphate groups, and scavenging free radicals to provide strong antioxidant protection. In the clinical dermatology and medical spa landscape of the Philippines, polynucleotides therapy is increasingly utilized for skin bioremodeling, correcting periorbital hollowing (tear troughs), minimizing fine lines, accelerating acne scar healing, and promoting hair follicle regeneration in cases of androgenetic alopecia (PDS, FDA).

Identities

Source Type	Identity
Wikipedia	Polynucleotide
Wikidata	Q424619
DBpedia	N/A
ProductOntology	N/A
Wiktionary	polynucleotide
Library of Congress Subject Headings (LCSH)	Polynucleotides
MeSH	Polynucleotides
NCBI Taxonomy	N/A
AGROVOC	N/A
Google Scholar	Polynucleotides skin rejuvenation fibroblast regeneration
ConceptNet	polynucleotide
OpenCyc	N/A

Also Known As

PN Therapy
PN Injectables
Salmon DNA Skin Booster
Biorejuvenation Therapy
Trout DNA Therapy
Rejuran (brand-specific)
PhilArt (brand-specific)
Plinest (brand-specific)
Nucleofill (brand-specific)

Geography and Climate

The tropical climate of the Philippines, characterized by high temperatures, intense ultraviolet (UV) radiation, and seasonal humidity variations, significantly influences the aging process of Filipino skin. Chronic sun exposure leads to premature photo-aging, characterized by solar elastosis, collagen depletion, and hyperpigmentation disorders such as melasma. Polynucleotides therapy is highly relevant in this climate because it does not cause photosensitivity, making it a safe year-round treatment option compared to aggressive chemical peels or ablative lasers during the peak summer months of April and May (PDS).

Geographically, the availability of polynucleotides therapy is concentrated within highly urbanized areas. Metro Manila serves as the primary hub, with clinics in Makati, Bonifacio Global City (BGC), and Quezon City leading the market. However, regional centers such as Metro Cebu, Metro Davao, and progressive cities like Iloilo and Bacolod are experiencing a growing presence of aesthetic centers offering this treatment. Patients in coastal and high-altitude areas (such as Baguio City) utilize the therapy to repair skin barrier damage caused by wind, salt, and intense mountain UV rays (PSA).

Demographics

The demographic profile of polynucleotides therapy patients in the Philippines spans a broad age group, primarily ranging from 25 to 65 years old. Younger cohorts (aged 25 to 35) typically seek the treatment for preventative skin quality improvements, active acne scar revision, and the correction of early signs of fatigue around the eyes. Older demographics (aged 36 to 65+) focus on correcting moderate-to-severe skin laxity, deep wrinkles, and neck or décolletage rejuvenation (PDS).

While female patients make up approximately 75% of the market, there is a rapidly expanding segment of male patients, particularly corporate professionals and public figures, who prefer polynucleotides due to their natural-looking results without the added volume associated with traditional hyaluronic acid fillers. The rising disposable income of the Filipino middle class, alongside the high concentration of business process outsourcing (BPO) professionals working night shifts, has also driven demand for polynucleotides to address periorbital dark circles and hollows caused by disrupted circadian rhythms (PSA).

Economy and Industry

The medical aesthetic industry in the Philippines has transitioned from a luxury market to a mainstream sector, driven by a growing middle class, social media exposure, and a cultural emphasis on personal appearance. Polynucleotides therapy represents a premium tier within the non-surgical skin booster market. A single session of polynucleotides therapy in the Philippines typically costs between ₱15,000 and ₱35,000, depending on the clinic’s location, the brand used (e.g., PhilArt, Plinest, or Rejuran), and the practitioner’s expertise. A standard protocol requires three to four sessions, translating to a significant financial commitment (PSA).

The supply chain relies entirely on the importation of medical devices and pharmaceutical products from specialized manufacturers in Italy, South Korea, and Switzerland. Authorized distributors, such as Neoasia and other regional healthcare companies, manage the importation, marketing, and distribution of these injectables to licensed clinics. The growth of the aesthetic sector has also contributed to job creation for medical professionals, including aesthetic nurses, dermatologists, and plastic surgeons, while stimulating secondary industries such as medical marketing and clinic administration software (FDA).

Transportation and Infrastructure

The success of polynucleotides therapy relies heavily on cold-chain logistics and sophisticated clinical infrastructure. Because polynucleotides are highly purified biological compounds, they must be transported and stored under strictly controlled temperature conditions, typically between 2°C and 25°C, to prevent degradation of the nucleic acid chains. Distributors utilize temperature-monitored vehicles and insulated packaging to deliver the syringes to clinics across the Philippine archipelago (FDA).

In terms of clinical infrastructure, polynucleotides therapy is administered in private dermatology clinics, multi-specialty medical centers, and high-end medical spas. These facilities are equipped with sterile treatment rooms, advanced skin diagnostic cameras, and emergency medical kits. The high density of premium clinics in central business districts like BGC and Makati is supported by modern transport networks, allowing local and international patients to access treatments easily via major thoroughfares and nearby international airports (PSA).

Culture and Tourism

The cultural emphasis on beauty, youthfulness, and healthy skin is deeply rooted in Philippine society. Influenced by both Western beauty standards and the more recent “K-Beauty” (Korean Beauty) trend, Filipinos increasingly value “glass skin”—a complexion that appears exceptionally clear, hydrated, and luminous. Polynucleotides therapy aligns perfectly with this cultural preference, as it improves the skin’s intrinsic quality, texture, and radiance from within, rather than masking imperfections with makeup (PDS).

Furthermore, the Philippines is positioning itself as a growing destination for medical and wellness tourism. Overseas Filipino Workers (OFWs) returning during the Christmas and summer holidays represent a significant portion of the seasonal patient base. Additionally, medical tourists from Australia, the United States, and neighboring Asian countries travel to the Philippines for aesthetic procedures. These visitors take advantage of lower treatment costs, combined with the renowned hospitality and high English proficiency of Filipino medical professionals, often combining their treatments with vacations in popular destinations like Boracay or Palawan (DOT).

Government and Administration

In the Philippines, the regulation of polynucleotides and other injectable aesthetic products falls under the jurisdiction of the Department of Health (DOH) and the Food and Drug Administration (FDA). The FDA classifies polynucleotide injectables as medical devices or prescription drug products, requiring a Certificate of Product Registration (CPR) or a Certificate of Medical Device Registration (CMDR) before import, distribution, and clinical use (FDA).

The professional administration of these injectables is restricted by the Professional Regulation Commission (PRC) to licensed physicians, specifically board-certified dermatologists and plastic surgeons. Clinics offering these services must hold valid sanitary permits from their respective Local Government Units (LGUs) and comply with DOH healthcare facility standards. The Philippine Dermatological Society (PDS) and the Philippine Association of Plastic, Reconstructive and Aesthetic Surgeons (PAPRAS) serve as self-regulating medical bodies that set ethical guidelines and coordinate with government agencies to suppress illegal clinics and unlicensed practitioners (PDS).

Education and Healthcare

The clinical education landscape in the Philippines has adapted to the rapid advancement of regenerative medicine. Training in polynucleotides therapy is integrated into continuing medical education (CME) programs, postgraduate dermatology residencies, and plastic surgery fellowships. Global manufacturers, in partnership with local distributors, regularly conduct hands-on workshops, masterclasses, and anatomical dissection seminars to train local physicians on advanced injection techniques (PDS).

From a healthcare safety perspective, polynucleotide injections are generally well-tolerated due to their high biocompatibility with human tissue. Because the DNA extraction process removes all protein allergens, the risk of immunological reactions or foreign body granulomas is extremely low. However, clinical protocols emphasize sterile techniques to prevent secondary bacterial infections at the injection sites. Practitioners are trained to recognize and manage rare complications, such as vascular occlusion, although such events are exceptionally rare with polynucleotides compared to traditional cross-linked dermal fillers (FDA).

Examples and Analogies

Cellular Fertilizer: Just as fertilizer does not artificially replace a plant but provides the nutrients required for the soil to regenerate and grow healthy crops, polynucleotides supply the necessary biological building blocks to stimulate the skin’s fibroblasts to produce its own collagen and elastin.
The Biological Alarm Clock: Over time, aging fibroblasts become dormant or “sleepy.” Polynucleotides act as an alarm clock by binding to A2A receptors, signaling the cells to wake up, multiply, and actively repair the surrounding dermal matrix.
A Structural Scaffold: In skin repair, polynucleotides form a temporary micro-structural network that supports cellular migration, enhances hydration, and facilitates the steady deposition of newly synthesized extracellular matrix components.

Usage Scenarios

1. Periorbital (Tear Trough) Rejuvenation

A 38-year-old female corporate manager presents with deep under-eye hollowing, thinning skin, and dark circles caused by chronic stress and sleep deprivation. Instead of using hyaluronic acid fillers, which carry the risk of the Tyndall effect (a bluish discoloration) or puffiness in the periorbital area, the dermatologist administers two sessions of polynucleotides. Over six weeks, the skin barrier thickens, microcirculation improves, and the under-eye hollows naturally soften without artificial volumization.

2. Acne Scar Revision in Fitzpatrick Skin Types IV and V

A 26-year-old male patient with dark Asian skin (Fitzpatrick Type V) seeks treatment for deep, rolling acne scars on his cheeks. Laser resurfacing alone carries a high risk of post-inflammatory hyperpigmentation (PIH) for his skin type. The physician combines subcision (physically breaking the scar tissue) with intradermal injections of polynucleotides. The polynucleotides accelerate the healing of the dermal wounds, suppress excessive inflammation, and promote organized collagen remodeling, leading to a smoother skin texture without hyperpigmentation.

3. Chronic Photo-damage Repair in Mature Skin

A 55-year-old male client who spends weekends golfing in Batangas presents with severe sun damage, skin laxity, and fine wrinkling on the neck and jawline. The dermatologist initiates a treatment plan consisting of three sessions of high-concentration polynucleotides spaced three weeks apart. The treatment stimulates elastogenesis and replenishes the depleted dermal matrix, restoring skin elasticity and reducing crepiness despite the patient’s ongoing exposure to tropical sunlight.

Strategies

Pre-Treatment Priming: Prepare the patient’s skin barrier with topical antioxidants (Vitamin C) and proper sunscreens for at least two weeks before starting polynucleotide injections to maximize fibroblast responsiveness.
Combination Protocols: Combine polynucleotides therapy with micro-needling, fractional lasers, or radiofrequency treatments. Administering polynucleotides immediately after energy-based treatments helps speed up recovery time and synergetically boosts collagen synthesis.
Injection Mapping: Use a micro-droplet technique (0.05 ml per injection point) spaced 0.5 to 1 cm apart across the target area, or use a blunt cannula for a single-entry fan technique in the periorbital zone to minimize bruising and swelling.
Maintenance Scheduling: Recommend a maintenance treatment every six months after the initial three-session loading phase to preserve the regenerative effects and counteract ongoing chronological and environmental aging.

Security and Safety Measures

Authenticity Verification: Always inspect the product packaging for holographic stickers, Neoasia security labels, and unique QR codes. Verify these markers on the distributor’s official portal to ensure the product is not a counterfeit or an parallel-imported item that bypassed cold-chain controls.
Patient Screening: Screen candidates for histories of severe seafood allergies, active skin infections (such as herpes simplex outbreaks), systemic autoimmune diseases, or bleeding disorders.
Aseptic Technique: Practice strict aseptic protocols, including double-cleansing the skin with chlorhexidine or isopropyl alcohol and performing injections in a sterile, dust-free clinical environment.
Post-Care Instructions: Instruct patients to avoid direct sun exposure, strenuous exercise, saunas, and makeup for the first 24 to 48 hours post-treatment. Emphasize the daily application of a broad-spectrum physical sunscreen (SPF 50+).

Historical Context

The scientific foundation of polynucleotides in medicine traces back to the late 20th century in Europe, where researchers investigated the wound-healing properties of DNA fractions extracted from trout and salmon. In Italy, the pharmaceutical company Mastelli pioneered the extraction and purification of these molecules, leading to the development of Polydeoxyribonucleotide (PDRN) and polynucleotides for clinical wound healing, treating diabetic foot ulcers, and accelerating skin graft donor site recovery (MeSH).

By the early 2010s, East Asian markets, particularly South Korea, recognized the aesthetic potential of these molecules, leading to the development of commercial skin boosters like Rejuran. In the Philippines, the therapy gained traction in the late 2010s and early 2020s, moving from niche dermatological clinics to mainstream popularity as patients and physicians sought natural, non-surgical regenerative alternatives to traditional cosmetic procedures. The introduction of products like PhilArt and Plinest further solidified the therapy’s position in the local market (PDS).

Challenges and Controversies

Market Proliferation of Unregistered and Counterfeit Products

A major challenge facing the Philippine aesthetic industry is the influx of cheap, unregistered polynucleotide and PDRN products sold online through unauthorized e-commerce platforms. These parallel-imported or counterfeit products bypass the cold-chain logistics required to maintain biological activity and safety. Administering these unverified substances increases the risk of contamination, severe allergic reactions, and late-onset granulomatous reactions in patients (FDA).

Patient Misconceptions and Unrealistic Expectations

Because polynucleotides are marketed as regenerative skin boosters, patients often confuse them with traditional dermal fillers or botulinum toxin, expecting immediate, dramatic changes in facial volume or muscle movement. Managing patient expectations is a constant challenge for dermatologists. Patients must be educated that polynucleotides work gradually over weeks to months, requiring multiple sessions to produce subtle, natural-looking improvements in skin health and structure rather than instant contour changes (PDS).

Regulatory Enforcement Gaps

While the FDA and professional societies issue regular advisories, enforcing regulations against unlicensed practitioners (such as salons and home-based “aesthetic clinics”) remains difficult. Unqualified personnel performing invasive injections without proper anatomical knowledge often lead to complications. This situation highlights the need for stronger enforcement of medical practice laws and increased public awareness campaigns to guide patients to board-certified medical professionals (FDA).